Thank you, Madam Chair.
My question is about Bill C-13, COVID-19 Emergency Response Act, passed in March 2020.
Under one of that bill's provisions, it would have been possible, until September 30, 2020, to override drug patents in case of health emergency and to import drugs that are not authorized for sale in Canada.
However, that provision was removed on September 30, 2020, and I would like to know why.